The samples had all initially been collected to detect flu using PCR tests, the same genetic screening process that can also be used to detect the presence of the novel coronavirus in patients infected at the time the sample is collected.
起初,医院采集这些样本是为了通过聚合酶链式反应(PCR)检测流感,同样的基因检测程序也可以用来检测患者在采样时是否感染了新冠病毒。
Each sample was retested several times to ensure there were no errors, he added.
科昂补充说,每个样本都进行了多次复检,以确保没有错误。
France, which has seen almost 25,000 people die from the virus since March 1, confirmed its first three COVID-19 cases on Jan 24, including two patients in Paris and another in the southwestern city of Bordeaux.
法国于2020年1月24日确诊了首批3例新冠肺炎病例,其中两名患者在巴黎,还有一名患者在西南部波尔多市。自2020年3月1日以来,法国已有近2.5万人死于新冠病毒感染。
Cohen said it was too early to know if the patient whose Dec 27 test was COVID-19 positive is France’s “patient zero”. Knowing who was the first is critical to understanding how the virus spread.
科昂说,现在还不清楚这名2019年12月27日样本新冠病毒检测结果呈阳性的患者是否是法国的“零号病人”。找到“零号病人”是了解新冠病毒如何传播的关键。
【法国医院发现去年12月已有新冠肺炎确诊病例】相关文章:
★ “大白兔冰淇淋”在美火爆,奶糖原料被抢光,冠生园:没授权啊
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15